(Q43550144)

24 November 2017

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients (English)

1 reference

24 November 2017

1 reference

Kwan-Hwa Chi

1

1 reference

24 November 2017

Yue-Cune Chang

2

1 reference

24 November 2017

Wan-Yao Guo

3

1 reference

24 November 2017

Mein-Jung Leung

4

1 reference

24 November 2017

Cheng-Yin Shiau

5

1 reference

24 November 2017

Sheng-Yu Chen

6

1 reference

24 November 2017

Ling-Wei Wang

7

1 reference

24 November 2017

Yuen-Liang Lai

8

1 reference

24 November 2017

Mau-Min Hsu

9

1 reference

24 November 2017

Shi-Long Lian

10

1 reference

24 November 2017

Ching-Hsiung Chang

11

1 reference

24 November 2017

Tsang-Wu Liu

12

1 reference

24 November 2017

Yung-Hsin Chin

13

1 reference

24 November 2017

Sang-Hue Yen

14

1 reference

24 November 2017

Cheng-Hwang Perng

15

1 reference

24 November 2017

Kuang Y Chen

16

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

International Journal of Radiation Oncology Biology Physics

24 November 2017

1 reference

24 November 2017

52

1 reference

24 November 2017

1238-1244

1 reference

24 November 2017

5

1 reference

Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

The role of chemotherapy in the management of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Is chemotherapy beneficial in the treatment of locoregionally advanced nasopharyngeal carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

Concurrent chemotherapy and radiation therapy for advanced stage carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902781-X

7 January 2021

10.1016/S0360-3016(01)02781-X

Identifiers

DOI

1 reference

24 November 2017

1 reference